Biogenic Synthesis and Characterization of Antimicrobial and Antiparasitic Zinc Oxide (ZnO) Nanoparticles Using Aqueous Extracts of the Himalayan Columbine (Aquilegia pubiflora)

Herein, we report a facile, economic, one-pot green synthesis of zinc oxide nanoparticles (ZnO-NPs) for diverse biomedical applications. In the study, ZnO-NPs were synthesized using an aqueous extract of Aquilegia pubiflora as an effective reducing and capping agent. The biomediated nanoparticles were characterized using various techniques including high-performance liquid chromatography (HPLC), X-ray diffraction, Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy, Dynamic light scattering, photoluminescence, and RAMAN. The particles were highly pure, having an average size of 34.23 nm with spherical or elliptical morphology, and displayed good aqueous dispersion capability. FTIR and HPLC confirmed the successful capping of flavonoids and hydroxycinnamic acid derivatives. The characterized NPs were then explored for their antimicrobial and anti-leishmanial potential. Among the tested bacterial and fungal strains, ZnO-NPs were more potent toward Pseudomonas aeruginosa and Fusarium solani with inhibition zone of 10.3 ± 0.19 mm and 13 ± 1.4 mm, respectively. A dose-dependent cytotoxic effect was observed against Leishmania tropica (KWH23) with significant IC50 for both the promastigote (48 μg/mL) and amastigote form (51 μg/mL) of the parasite. In addition, bacterial kinase enzymes were inhibited by ZnO-NPs, thus allowing us to elaborate a possible action mechanism. Finally, the remarkable biocompatible nature of the particles was confirmed against freshly isolated human red blood cells (hRBCs). Altogether, these results affirmed the high antimicrobial and antiparasitic potential of ZnO-NPs obtained through a biogenic synthetic approach using aqueous extract of the Himalayan Columbine (Aquilegia pubiflora). Graphical Abstract Schematic flow for synthesis and Biomedical application of ZnO-NPs.


INTRODUCTION
In recent years, the development of environmentally friendly techniques for the synthesis of nanoscale materials has become a major focus for material scientists (Iravani, 2011). In this regard, plant-based synthesis of NPs is a growing trend in green chemistry that is considered facile, inexpensive, and nontoxic (Bala et al., 2015;Duan et al., 2015). Over the past decade, extensive research on metal oxide NPs has been focused due to their numerous applications in various technological sectors (Altavilla and Ciliberto, 2011). Among metallic nanoparticles, zinc oxide nanoparticles (ZnO-NPs) are promising inorganic materials with multifaceted advantages. Excellent optical, semiconducting, and piezoelectric properties and chemical sensing make ZnO-NPs to be exploited across various industries such as composites, cosmetics, catalysis, energy storage, electronics, textile, and health (Hatamie et al., 2015;Kumar and Rao, 2015;Al-Naamani et al., 2016;Sankapal et al., 2016). The NPs are nontoxic, biocompatible, and inexpensive and exhibit various biomedical applications including their use as antimicrobial and antiparasitic agents (Cai et al., 2016).
Though chemical and physical methods for synthesis of ZnO-NPs offer a couple of advantages, they suffer from considerable drawbacks. The physical methods of synthesis are accompanied with high-energy requirements while chemical synthesis involves the use of noxious chemicals, making both the methods environment unfriendly, expensive, and laborious (Diallo et al., 2015).
To overcome the problems of hazardous waste and energy, green synthesis of NPs has been proposed and successfully harnessed for the synthesis of ZnO-NPs; therefore, a paradigm shift can be observed toward the bio-nano interface. Among the various biological resources (plants, bacteria, algae, and fungi), plants provide an ideal platform for the biosynthesis of NPs (Thema et al., 2015). The biogenic synthesis of ZnO-NPs has already been demonstrated; however, limited data is available on their diverse biological properties.
Here, we report a rapid, room-temperature synthesis of the ZnO-NPs via a complete environmentally friendly procedure which involves the use of aqueous extracts of Aquilegia pubiflora as an effective oxidizing/reducing as well as capping agent. A. pubiflora is an important native plant with well-documented medicinal uses. Traditionally, the plant is used for varied ailments including hepatitis, wound healing, treatment of skin burns, jaundice, and circulatory and cardiovascular diseases (Hussain et al., 2011;Adnan et al., 2012;Ahmed and Murtaza, 2015;Thatoi et al., 2016). Owing to its ease of availability and medicinal importance, the plant was employed for biosynthesis of ZnO-NPs for a broad range of therapeutic applications.
To the best of our knowledge, it is the first-ever report on A. pubiflora-mediated synthesis of ZnO-NPs. The NPs were well characterized by high-performance liquid chromatography (HPLC), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), scanning electron microscopy (SEM), Raman spectroscopy, and photoluminescence (PL). The well-characterized NPs were then investigated for their antimicrobial and anti-leishmanial and protein kinase (PK) inhibition potential. Moreover, to ensure the biocompatible nature hemocompatibility of the NPs against freshly isolated human red blood cells (hRBCs) was also investigated.

Collection and Processing of the Plant Material
The herb reported in the current study was collected from District Swat (Main Damm), Khyber Pakhtunkhwa, Pakistan. The plant was taxonomically identified as A. pubiflora at the Department of botany, Bacha Khan University, Charsadda, and later on verified at the Department of Plant Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
The fresh and fine leaves of the plant were excised into small pieces through a sterile surgical blade, rinsed well with distilled water to remove any dust particles and impurities, followed by shade drying. The well-dried leaves were then ground into fine powder in a Willy mill and stored at 25 • C for aqueous extraction.
Aqueous leaf extract of plant material was prepared by adding 30 g of fine powder in flasks (500 ml) containing 200 ml of distilled water, sonicated continuously for 10 min, and kept in a shaking incubator at 200 rpm for 2 days at 37 • C. The prepared extract was initially filtered twice with nylon cloth to remove solid residues, and the obtained extract was further filtered using Whatman filter paper three times to remove any remaining particulates. The fresh filtrate was then processed for further use.

HPLC Analysis
Samples were analyzed by HPLC following aqueous extraction as described above. The HPLC system was composed of a Varian HPLC system with a Varian Prostar 230 pump, a Metachem Degasit degasser, a Varian Prostar 410 autosampler, and a Varian Prostar 335 Photodiode Array Detector (PAD). The HPLC system was driven by Galaxie version 1.9.3.2 software (Varian, Le Plessis-Robinson, France). HPLC-grade standards were obtained from Sigma-Aldrich. The technique used for separation is adapted from Bourgeois et al. (2016). Here, Hypersil PEP 300 C18, 250 × 4.6 mm, 5 µm particle size equipped with a guard column Alltech, 10 × 4.1 mm, was used at 35 • C. Compound detection was achieved at 280 nm. The mobile phase was composed of a mixture of solvent A = HCOOH/H 2 O, pH = 2.1, and solvent B = CH 3 OH (HPLC-grade solvents). The mobilephase composition varied during a 1-h run, with a nonlinear gradient as follows: 8% B (0 min), 12% B (11 min), 30% B (17 min), 33% B (28 min), 100% B (30-35 min), and 8% B (36 min) at a flow rate of 1 mL/min. A 10-min re-equilibration was applied between each run. Quantification was based on external 5-point calibration curves with R 2 of at least 0.999 using commercial reference standards (Sigma-Aldrich; Table 1). All the samples were analyzed thrice, and the results expressed in µg/mg DW of the sample.

Biosynthesis of ZnO Nanoparticles
Zinc oxide nanoparticles were synthesized according to a previously described protocol with slight modifications (Thema et al., 2015). Briefly, 6.0 grams of zinc acetate dihydrate (Zn (CH 3 COO) 2 ·2H 2 O (Sigma-Aldrich) was added to 100 ml extract and kept on a magnetic stirrer at 60 • C for 2 h. Once the reaction was completed, the mixture was allowed to cool down at 25 • C, centrifuged (HERMLE Z326K) at 10,000 rpm for 10 min. The supernatant was discarded and the remaining pellet was washed thrice with distilled water, poured into a clean Petri plate, and oven-dried at 90 • C. The dried material was then grounded into fine powder in pestle and mortar and calcinated for 2 h at 500 • C to remove any impurities. The annealed powder was stored in an airtight glass vial, labeled as ZnO-NPs, and was further used for physical characterization and biological applications.

Physicochemical and Morphological Characterization
Several characterization techniques including XRD, FTIR, PL, SEM, RAMAN spectroscopy, dynamic light scattering (DLS), and dispersion studies were carried out to evaluate the structural, chemical, vibrational, and morphological properties of biosynthesized ZnO-NPs. To determine the crystalline nature, XRD (Model-D8 Advance, Germany) was carried out in the range of 2 O (10 • -80 • ) with a step time of 0.55 s and scanning step size of 0.03 • /s. Diffraction data were obtained through Cu Kα radiation (wavelength, 1.5406 Å; generator voltage, 40 kV; and tube current, 30 mA). About 1 mg of powdered ZnO-NPs was used for analysis. To calculate the crystallite size, Scherer's equation was used as follows: where D denotes crystallite size, k represents the shape factor (0.94), λ depicts the X-ray wavelength which was 1.5421 Å, and β and θ refer to the full width at half maximum in radians and Bragg's angle, respectively. To determine the associated functional groups on NPs, with capping and reducing agents within the extract as a result, FTIR and HPLC were carried out. The dispersion stability of the particles was investigated visually in distilled water with varied pH as a function of storage time. Morphological attributes were examined through SEM. DLS of biogenic ZnO-NPs was performed to determine the zeta potential and size distribution. RAMAN spectroscopy of biogenic ZnO-NPs was performed in the spectral range of 200 to 700 cm −1 to find the vibrational modes of NPs while room temperature PL spectra were determined in the spectral range of 500 to 900 nm.

Antibacterial Assay
The agar well diffusion method, as documented, previously was used with some modifications for the assessment of in vitro bactericidal potential of ZnO-NPs against different bacterial strains (Thatoi et al., 2016). The seeding density (1 × 10 6 CFU/mL) of the bacterial culture was optimized. 50 µL of refreshed cultures in nutrient broth was used to prepare lawn on the nutrient agar plates. Each well was carefully filled with 10 µL of the test sample. Accordingly, the seeded plates were labeled. Cefixime and roxithromycin (standard antibiotics), and DMSO acted as positive and negative controls, respectively. After incubation for 24 h at 37 • C, each well loaded with tested samples and positive-negative controls were checked for the appearance of a zone of inhibition (ZOI). The diameter of zones was measured in mm with a Vernier caliper.

Antifungal Assay
The agar well diffusion method (Ahmad et al., 2016) with slight modifications, was used to evaluate the antifungal potency of ZnO-NPs. In brief, a sterile SDA medium was poured in autoclaved plates and a 100-µL spore suspension of every fungal strain was taken and swabbed on solidified media in Petri plates. Each tested sample (10 µL) was applied into sterilized wells in the agar plates. The seeded plates were labeled accordingly. DMSO and clotrimazole were carried as negative and positive control, respectively. Plates were incubated at 28 • C for 24-48 h to visualize the fungal growth. After incubation, each loaded disk with tested samples, and controls was checked for the appearance of ZOI (zone of inhibition). The diameter of ZOI was measured using a Vernier caliper to the nearest mm.

Protein Kinase Assay
Protein kinase enzyme inhibition assay was performed to verify the PK inhibition ability of anti-cancerous potentials of biogenic ZnO-NPs with slight modifications in protocol elucidated by Fatima et al. (2015). A medium (TSB broth) was made ready, autoclaved at 121 • C for 20 min, and incubated for 24 h to confirm any impurity. Both Streptomyces strains and autoclaved TSB broth were kept in a shaking incubator at 30 • C for 24 h. Except for agar, starch, and calcium carbonate, all the remaining ingredients were added with 300 mL of distilled water and mixed constantly with a stirrer. Starch, calcium carbonate, and agar were dissolved in 200 mL of distilled water in a separate flask. Both the solutions were finally mixed to make the final concentration of 500 mL. The medium was autoclaved and emptied to autoclaved Petri plates under antiseptic conditions to avoid contamination. The medium was kept solidified, and Streptomyces strain in the culture broth was uniformly spread on the surface of the media with autoclaved cotton buds. A sterile borer was used for making wells, and molten agarose was added to the bottom of the wells to avoid diffusion of the test samples. Afterward, 20 µL of the serially diluted sample was added to each well and kept intact for a few minutes to avoid aggregation of the poured sample in wells. Surfactin was assessed as positive control. Petri plates were properly labeled and kept for incubation at 37 • C for 24-48 h. Using a Vernier caliper, zones of inhibition were measured in mm after 48 h, respectively.

Anti-leishmanial Assay
The anti-leishmanial potential of the biogenic ZnO-NPs was assessed against the amastigote and promastigote cultures of L. tropica KWH23 (Department of Biotechnology, BKUC, Pakistan; Ahmad et al., 2015). M199 media having 10% fetal bovine serum helped in the culture of leishmanial parasites. Leishmania culture at a density of 1 × 10 6 cells/mL was used for the analysis. The activity was executed in a 96-well plate with concentrations ranging from 400 to 25 µg/mL. DMSO was used as blank, and amphotericin was used as a positive control. The seeded 96-well plate with test dilutions was incubated at room temperature for 72 h. OD was noted at 540 nm, while all the lived cultures were counted using an inverted microscope, and their LC 50 values were calculated by applying TableCurve software. Percent inhibition was measured as

Biocompatibility of ZnO Nanoparticles With RBCs
The biocompatibility of ZnO-NPs was probed against freshly isolated hRBCs to assess the bio-safe nature (Matinise et al., 2017). About 1 mL of blood was collected from healthy individuals with informed consent. The isolated blood was poured in the EDTA tube to prevent blood clotting. For isolation of erythrocytes, blood was centrifuged at 12,000 rpm for 7 min. Once centrifugation was completed, the supernatant was discarded, and the remaining pellet was washed three times with phosphate-buffered saline (PBS). 200 µL of erythrocyte suspension was mixed with 9.8 mL of PBS (pH: 7.2) and gently shook for preparing PBS-erythrocyte suspension. Different concentrations of NPs along with prepared erythrocyte suspension were taken in eppendorf tubes and incubated for 1 h at 35 • C. All the reaction mixtures were centrifuged at 10,000 rpm for 10 min after incubation. 200 µL of the supernatant was transferred from each tested sample in a 96-well plate, and absorption was recorded for hemoglobin release at 540 nm (0.5%). Triton X-100 was used as a positive control while DMSO was employed as a negative control. Percentage hemolysis was calculated as

Synthesis and HPLC Analysis of Green ZnO-NPs
In the current study, an aqueous leaf extract of A. pubiflora was utilized as a reducing and stabilizing agent for the synthesis of multifunctional ZnO-NPs. To the best of our knowledge, it is the first-ever study on A. publiflora-mediated synthesis of metallic nanoparticles. Genus Aquilegia belongs to the family Ranunculaceae that has more than 60 plant species, which are used for several medicinal purposes around the world, mainly in South Asia. The species are rich in medicinally important phytochemicals including aquilegiolide, apigenin, β-sitosterol, berberine, caffeic acid, genkwanin, glochidionolactone A, ferulic acid, magnoflorine, p-coumaric acid, and resorcylic acid (Bylka et al., 2002;Yu et al., 2007;Mushtaq et al., 2016). These phytochemicals including phenolics and flavonoids could have played an essential role in the synthesis of stable nanoparticles. To determine and quantify the specific phytochemicals responsible for reducing and successful capping, HPLC was performed. A total of eight compounds including four flavonoids (vitexin, isovitexin, orientin, and isoorientin) and four hydroxycinnamic acid derivatives (sinapic acid, chlorogenic acid, ferulic acid, and p-coumaric acid) were detected and quantified for both aqueous leaf extract and synthesized ZnO-NPs, as shown in Figure 1. Flavonoids and hydroxycinnamic acids are phenolics, produced through the shikimic acid pathway and are responsible for performing various biological activities of plants (Nazir et al., (Lam et al., 2016;Naveed et al., 2018). The presence of flavonoids and hydroxycinnamic acid derivatives on the surface of nanoparticles is according to the results of our previous reports Shah et al., 2020). These  Values are means ± standard deviations (SD) of 3 independent experiments. nd: not detected (below the LOD).
plant active compounds are considered to be involved in the capping of ZnO-NPs, as shown in Figure 2. After subsequent steps of washing, drying, grinding, and calcination, white powder of ZnO-NPs was obtained. The fine powder collected was stored in an airtight glass vial, labeled as ZnO-NPs, and was stored at room temperature for physicochemical, morphological characterization, and biological applications.

XRD (X-Ray Diffraction) Analysis
The phase identification, structure, and purity of the biosynthesized ZnO-NPs were investigated through XRD. The XRD pattern ( Figure 3A)

Fourier Transform Infrared Spectroscopy
Fourier transform infrared spectroscopy was used to examine the surface adsorption of functional groups on biosynthesized nanoparticles. Figure 3B depicts typical FTIR spectra in the spectral range of 400-4000 cm −1 . The major absorption peaks were observed in the region of lower wave numbers. A broad band observed at 3100 cm −1 corresponds to the O-H stretching mode of hydroxyl groups (Vijayalakshmi et al., 2016). The peak intensity at 1459 cm −1 showed amine (-NH) vibration stretch in protein amide linkages (Jamdagni et al., 2018). The intense bands observed at 1028 cm −1 and 1384 cm −1 represented alcohols, phenolic groups, and C-N stretching vibrations of aromatic amines of biomolecules (Huang et al., 2007). A characteristic band observed at 863 cm −1 corresponds to the Zn-O stretching bond (Taş et al., 2000;Sangeetha et al., 2011). FTIR spectra affirm successful capping of biomolecules on the NP surface and thus provide stability and dispersion capacity to ZnO-NPs in aqueous media.

Scanning Electron Microscopy Analysis
The surface morphology and particle size of the green synthesized ZnO-NP were determined using SEM. Figures 4A,B show typical scanning electron micrograph NPs. As can be seen from the micrographs, the particles exhibit a sphere-shape morphology with extent of aggregation. Such morphologies were also reported in previous studies (Davar et al., 2015; FIGURE 2 | Mechanistic approach for the synthesis of ZnO-NPs through plant active compounds. Frontiers in Materials | www.frontiersin.org  Frontiers in Materials | www.frontiersin.org 7 August 2020 | Volume 7 | Article 249 Suresh et al., 2015;Khan et al., 2018). For instance, in a study, sphere-shaped nanoparticles were reported using aqueous leaf extract of three plants, i.e., Abutilon indicum, Clerodendrum infortunatum, and Clerodendrum inerme. Moreover, the average particle size of the nanoparticles as calculated using ImageJ software was found to be 34.23 nm.

Dispersion Studies
Dispersion plays a vital role in determining functional activities of the engineered nanoparticles in any biological system (Bihari et al., 2008). Several parameters affect the dispersion capacity of the nanoparticles such as presence of charged or uncharged molecules that are adsorbed on the particle surface and the ionic strength of the solvent (Modena et al., 2019). In order to investigate the dispersion capability of ZnO nanoparticles, distilled water at different pH values was used. Figure 4C illustrates the dispersion capacity of ZnO-NPs at pH: 2, pH: 7, and pH: 12. It was observed that ZnO exhibited excellent dispersibility at neutral pH even after 24 h of sonication. The results were later augmented by a highly negative zeta potential value at neutral pH, which quantifies the stable dispersion capability of nanoparticles.

Dynamic Light Scattering
Zeta potential and size distribution of the particles was investigated using a Malvern zeta sizer. Zeta potential (ζ) is a typical measurement of the surface charge and defines colloidal stability of the particles. Suspensions that feature | ζ| ≥ 15 mV are generally categorized as stable colloids (Modena et al., 2019). The zeta potential of synthesized ZnO-NPs in distilled water was recorded as −18.4 mV and can thus be considered as stable colloidal solution in Figures 5A,B. The measurement augments and verifies the stable dispersion capability of biogenic ZnO nanoparticles in distilled water with pH 7. The negative surface charge on particles is due to the high binding affinity of the extract compounds on metallic ions conferring the particles' dispersion stability and preventing from aggregation (Vimala et al., 2014). Moreover, size distribution measurements revealed the average size of the particles to be 131 nm with a polydispersity index (PDI) of 0.340. As the graph shows, the particle size is polydispersed and is larger as compared to the SEM measurements. The larger size of the ZnO-NPs observed via DLS is due to the biasness of the technique toward measurement of larger particles (even aggregate; Modena et al., 2019).

Photoluminescence and Raman Spectra
The photoluminescence study of engineered nanomaterials (ENMs) is important as it provides important information about the quality of the synthesized materials. Figure 5D illustrates room temperature PL spectra of ZnO-NPs. PL measurement was performed at excitation wavelength of 500 to 900 nm. Characteristic peaks were observed at 510, 552, and 690 nm referred to as trap-state or deep-state emission (Uthirakumar and Hong, 2009). It is proposed that the oxygen vacancies in ZnO exist in three charge states, i.e., neutral, singly ionized, and double ionized. Green emission from ZnO-NPs is due to existence of oxygen (Raoufi, 2013) related to the increase in oxygen vacancies and thus increase in PL emission. Figure 5C shows Raman spectra of the biosynthesized nanoparticles that displayed characteristic peaks at 435 and 572 cm −1 . Similar Raman patterns were also reported in some previous studies (Diallo et al., 2015).

Antibacterial Activity
Pathogenic bacteria and fungi cause a broad range of diseases in both humans and animals. Extensive research and sophisticated scientific approach have become inevitable for the establishment of new therapeutic values to overcome microbial resistance and the nonselective and unsystemic use of antibiotics. In the study, antibacterial activity of phyto-fabricated ZnO-NPs was determined against five pathogenic bacteria including two Gram-positive (Bacillus subtilis and Staphylococcus epidermidis) and three Gram-negative (Klebsiella pneumonia, Escherichia coli, and Pseudomonas aeruginosa) using agar well diffusion method as shown in Table 3. An example of ZnO-NP activity against S. epidermidis is shown in Figure 6A. Five different concentrations (5, 4, 2, 1, and 0.5 mg/mL) were used to probe the bactericidal potential of NP formulations. In general, all the tested strains showed dose-dependent susceptibility to ZnO-NPs with P. aeruginosa and B. subtilis found to be the most susceptible. Inhibition zones measured at 5 mg/mL were 10.3 ± 0.19 for P. aeruginosa, 9.5 ± 0.31 for Bacillus subtilis, 8.7 ± 0.18, and 8.7 ± 0.23 for both K. pneumonia and E. coli while 7.1 ± 0.24 for S. epidermidis. Most of the mechanistic models for antibacterial activity of ZnO-NPs are based on the surface-to-volume ratio, size, and physicochemical properties.
Though antimicrobial mechanisms of metallic nanoparticles are subject to ongoing research, few models have been demonstrated in literature that explain the inhibitory mechanism of NPs. According to the studies, the growth inhibition effect of ZnO-NPs is the result of one or a combination of the following mechanisms: (1) electrostatic interaction between microbial cell wall and ZnO-NPs leading to cell wall destruction and thus compromise of cell integrity; (ii) accumulation of ZnO-NPs and subsequent release of Zn +2 within the bacterial cell; and (iii) formation of reactive oxygen species (ROS; Sirelkhatim et al., 2015;Król et al., 2017). Numerous studies have suggested ROS generation as a key mechanism responsible for the antimicrobial potential of ZnO-NPs. ROS results in DNA damage, disrupting cellular membranes and proteins and ultimately leading to cell death (Raghupathi et al., 2011). Hydroxyl radical (OH-), hydrogen peroxide (H 2 O 2 ), and superoxide anion (O −2 ) are the most abundant reactive oxygen species found in aqueous suspension of ZnO-NPs. Among these, -OH is the most reactive species and reacts with any type of biomolecule within the living cells. Such biochemical reactions may lead to recombination of two -OH ions to form H 2 O 2 . Hydrogen peroxide is a relatively weak oxidizer but may also result in cell damage. Unlike -OH and H 2 O 2 , superoxide anion radical (O −2 ) has weak penetration potential and is less toxic (Hameed et al., 2015). These reactive oxygen species are produced on the surface of ZnO-NPs in aqueous media. In subsequent steps, the electrons and the holes on the ZnO-NP surface interact with water (H 2 O) molecules in the surrounding medium and form OH and H + . In separate reactions, O 2 molecules yield superoxide anion (O-2 ), which further produces HO 2 · by reacting with H + . Furthermore, the reaction between electrons generating (HO 2 ) and H + yield (H 2 O 2 ) molecules, which has the capacity to penetrate cellular membranes, and ultimately damage or kill the bacteria cells (Xie et al., 2011;Sirelkhatim et al., 2015).

Protein Kinase Inhibition Activity
Protein kinase, a kinase enzyme, has a significant importance in anticancer therapies. The enzymes play a key role in the phosphorylation of serine-threonine and tyrosine residues; these residues are helpful in certain regulatory and controlling processes for metabolism, apoptosis of cells, and cellular proliferation/differentiation. Decontrolled phosphorylation can Star *-*** represent; *** highly significant, ** slightly significant, and * non-significant difference from control at P < 0.05 by one-way ANOVA in the column. Values are mean ± SD of triplicate.  cause and induce genetic abnormalities, leading to tumorigenesis. Therefore, all those products which have the ability to deter PK enzymes can be of significant importance in cancer research (Yao et al., 2011). PK phosphorylation also plays a vital role in the formation of hyphae in Streptomyces fungal strains, and the same principal is applied to determine the PK inhibition activity. The Streptomyces 85E strain was used to investigate medicinal compounds for investigation of the PK inhibition (Waters et al., 2002). For the preliminary anticancer screening, ZnO-NPs in different concentration were evaluated for PK inhibition. DMSO and surfactin were used as negative and positive controls, respectively. Like antimicrobial activity, ZnO-NPs also displayed dose-dependent potential against PK and the highest ZOI was observed on 5 mg/mL as 17 ± 1.22 mm while the lowest ZOI was recorded as 6.3 ± 1.72 mm at 500µg/ml concentrations, respectively, as shown in Figure 7. Such an excellent activity of ZnO-NPs is a preliminary indication of its anticancer potential and can be considered for detailed in vitro and in vivo anticancer studies.

Anti-leishmanial Assay
Leishmaniasis is a tropical and subtropical disease with annual incidence of 1.5 to 2 million cases worldwide. According to the World Health Organization (WHO), the disease is endemic in 89 countries and results in 70,000 deaths each year. The disease is caused by an intracellular parasite and is transmitted to humans by sand fly (phlebotomies and Lutzomyia) bite. Due to the inappropriate vector and inefficient and affordable drugs, the disease is at high risk of uncontrolled spreading. Recently, metal-oxide nanoparticle (oxides of zinc, silver, titanium, and magnesium)-based treatments have gained popularity because of their significant cytotoxic potential against Leishmania (Jebali and Kazemi, 2013). However, biosynthesized ZnO-NPs have Values are means ± standard deviations (SD) of 3 independent experiments. Different letters represent significant differences between the various extraction conditions (p < 0.05).
been rarely explored for their cytotoxicity against the parasite Leishmania tropica (KWH23). In the current study, ZnO-NPs in the range of 12.5-400 µg/mL were investigated via MTT cytotoxic assay against the promastigote and amastigote axenic cultures of L. tropica (Figure 8). ZnO-NP formulations were found to have dose-dependent lethality with significant mortality of 85% ± 2.7 and 81% ± 3.1 at 400 µg/mL against the parasite in promastigote and amastigote form, its morphological form being round-shaped in human host. Least mortality observed was 26.43% ± 2.4 and 29.07% ± 2.9 at the tested concentration of 12.5 µg/mL. The IC 50 values were calculated as 48 µg/mL for promastigote and 51 µg/mL for amastigote. Our findings are in agreement with previous studies and thus emphasize on the futuristic possibilities for ZnO-NPs in anti-leishmanial therapies.

Biocompatibility Studies of ZnO-NPs
Biocompatibility of ENMs is a key requirement for their multifaceted biomedical applications. To evaluate the biosafe nature, ZnO-NPs were investigated for their compatibility against hRBCs. In the experiment, freshly isolated hRBCs and NP formulations were co-incubated in PBS that mimic the extracellular environment (Evans et al., 2013). The assay is based on the release of hemoglobin from red blood cells (RBCs), which can be induced by the test sample if it has the capability to rupture RBCs. The RBCs lysis is then quantified by measuring the hemoglobin release in the medium spectrophotometrically (405 nm; Amin and Dannenfelser, 2006). The NPs were screened at 400 µg/mL for hemolytic activity, shown in Table 5. Generally, any hemolysis ≥ 25% is considered hemolytic while hemolysis ≤ 10% is considered nonhemolytic. In the current study, ZnO-NPs exhibited remarkable hemocompatibility even at the highest tested concentration. The study thus concludes that A. pubiflora ZnO-NPs are highly biocompatible and can be used for diverse biomedical applications.

CONCLUSION
The recent research work is focused on the bioaugmented synthesis of ZnO-NPs using aqueous extract of medicinally important A. pubiflora. The crystalline nature of the synthesized NPs was confirmed by XRD analysis. HPLC and FTIR analysis confirmed the presence of phytochemicals involved during the conversion of metallic ions into nanoparticles. Morphology and vibrational modes were determined through SEM and RAMAN spectra, while surface charge and stability were determined through DLS. Synthesized ZnO-NPs showed effective antimicrobial (antibacterial and antifungal) and antiparasitic (anti-leishmanial) activities. The bioengineered ZnO-NPs have also exhibited an effective inhibitory potential against microbial PKs. It was also found that synthesized ZnO-NPs are biocompatible with hRBCs. Our experimental work concluded that the abovementioned ZnO-NPs have a great potential for various cosmetic or medicinal applications as biocompatible antimicrobial and antiparasitic agents. However, further research on ZnO-NPs to exploit its biomedical potential on both in vitro and in vivo levels has to be conducted.

DATA AVAILABILITY STATEMENT
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation, to any qualified researcher.

ETHICS STATEMENT
Ethical review and approval was not required for the study on human participants in accordance with the local legislation and institutional requirements. The patients/participants provided their written informed consent to participate in this study.

AUTHOR CONTRIBUTIONS
HJ performed the experiments, compiled the data, and prepared the manuscript. MS assisted in experiments. HU helped in biological assays. MK helped in characterization of NPs. MZ helped in characterization of NPs. CH performed HPLC and reviewed the manuscript. BA supervised the research and critically reviewed the manuscript. All authors contributed to the article and approved the submitted version.